Skip to site content

2017 Catalog: All Courses

To view other courses in this category, use the “Previous” and “Next” buttons. To select this course and request approval, please login. Need more help reading this page?

DE0082: IHS Clinical Rounds:: Co-Prescribing Naloxone

Date: 2/17/2017 - 2/17/2017
Course Status: Completed
Facility: Online
Location: Online
Director: Mary Toledo
Level: Basic
Audience: Dentists, Hygienists, Assistants, Support Staff
Quota: 1 - 500 students
Tuition: $0.00
Hours: 1.00 (Total CDE); 1.00 (DANB Non-Clinical); 1.00 (AGD - 142)
Joint Sponsorship: No
Lecture icon Question and Answer icon Discussion icon

This is a webinar sponsored by the IHS Clinical Rounds on Friday, February 17, 2017, 12-1 Eastern Time.

Registration/Connection Information
There is no fee to participate in this webinar. The session is open and registration is not required. Use the link/ instructions below on the day of the presentation to be connected.

1. Go to:
Please sign in 10 minutes before the listed start time to hear important navigation instructions.
2. Select the “Enter as a Guest” option.
3. Input your name [first and last] in the Name box.
4. The passcode is: rounds
5. Press the “Enter Room Button”

All sessions are recorded and can be accessed at: Please note that CE credit is not available for viewing recorded versions of the webinars.

Questions & Technical Assistance: Send e-mail to

Learning Objectives:

Upon completion of this webinar, participants will be able to:
1. Recognize the role of Co-prescribing Naloxone as part of a Harm Reduction and Risk Mitigation Strategy to prevent opioid overdoses.
2. Implement the national response strategies to reduce opioid overdose deaths.
3. Develop collaborative practice agreements for pharmacists and local first responders.

Speaker / Presenter:

Kailee Fretland — For follow-up questions, please contact the speaker at

Jennie Wei — For follow-up questions, please contact the speaker at

Disclosure Policy:

It is the policy of the Indian Health Service, Division of Oral Health, that faculty/planners disclose any financial or other relationships with commercial companies whose products may be discussed in the educational activity. The Indian Health Service, Division of Oral Health, also requires that faculty disclose any unlabeled or investigative use of pharmaceutical products and medical devices. Images that have been falsified or manipulated to misrepresent treatment outcomes are prohibited.

None of the faculty/planners for this activity has a conflict of interest, and there is no use of unlabeled or investigative pharmaceutical products or medical devices. No images have been falsified or manipulated to misrepresent treatment outcomes.The educational objectives, content, and selection of educational methods and instructors are conducted independent of any commercial entity.

The IHS Division of Oral Health is an ADA CERP Recognized Provider

The IHS Division of Oral Health is an accredited sponsor of continuing education under the American Dental Association Continuing Education Recognition Program (CERP). ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the IHS at IHS CDE Coordinator or to the Commission for Continuing Education Provider Recognition at



Tuition Payment Information:


Tuition Policy:

Tuition must be paid in full 8 weeks prior to the start date of any course. Request for refunds must be received in writing at least two weeks before the course begins. For each refund request, there will be an administrative charge of $100. No refunds will be made to registrants who fail to attend a course. If IHS CDE program cancels a course, then 100% of the tuition will be refunded.